Cefuroxime Axetil Tablets
Formulation (FDF) · Tablets · 0.125g; 0.25g
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Cefuroxime Axetil Tablets
- Dosage Form
- Tablets
- Strength
- 0.125g; 0.25g
- Therapy Area
- Infectious Diseases
- Indication
- Lower respiratory tract infection; Acute bronchitis; Acute exacerbation of chronic bronchitis; Pneumonia; Upper respiratory tract infection; Otitis media; Sinusitis; Tonsillitis; Pharyngitis; Genitourinary tract infection; Pyelonephritis; Cystitis; Urethritis; Skin infection; Soft tissue infection; Impetigo; Pyoderma; Rash pustular; Gonorrhoea; Gonococcal urethritis; Gonococcal cervicitis
- Current Status
- Official FDF licensing catalog (UB281)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price